Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj crawled time : 13:00 save search
White River Bancshares Co. Earns $509,000, or $0.51 Per Diluted Share, in First Quarter 2024; Highlighted by Higher Net Interest Income and Double Digit Loan and Deposit Growth Year-Over-Year
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
first growth
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
miss
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CODI | News | $22.605 1.23% 58K
|
Finance
|
| O: 0.36%
H: 0.0%
C: 0.0%
pot honey
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $25.57 3.98% 4.1K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | News | $25.57 3.98% 4.1K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
companies biopharma platform
Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year
Published: 2024-04-12 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
expected year revenue for financial
engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
ENGN | $14.58 2.89% 5.8K
|
n/a
|
| O: -4.12%
H: 4.93%
C: 2.34%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals ...
Published: 2024-04-02 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug patent schizophrenia
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
Published: 2024-04-01 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.04%
commercialization
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: -0.35%
H: 0.4%
C: 0.36%
series therapeutics
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Published: 2024-03-12 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
ARTL | $1.28 4.1K
|
Health Technology
|
| O: 2.01%
H: 6.41%
C: 0.36%
innovation
EU Panel Backs J&J, Legend’s Carvykti for Second-Line Multiple Myeloma
Published: 2024-02-26 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
carvykti
Four Drugmakers to Face Government Together in IRA Oral Arguments Next Month
Published: 2024-02-21 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
J&J Wins Bi-Weekly Dosing Approval from FDA for Tecvayli in Multiple Myeloma
Published: 2024-02-21 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
fda tecvayli approval
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
MURA | $3.68 3.08% 120K
|
|
| O: 2.78%
H: 8.11%
C: 3.53%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
ALKS | $23.735 -0.11% 620K
|
Health Technology
|
| O: 2.72%
H: 13.77%
C: 13.25%
year financial results
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
MGTX | News | $5.005 -0.1% 84K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: -8.87%
million pharmaceuticals milestone
Johnson & Johnson's nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)
Published: 2024-02-09 (Crawled : 13:00) - prnewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
fda disease granted treatment risk designation therapy
FDA Sets Adcomm for BMS, J&J CAR T Therapies Amid Class-Wide Concerns
Published: 2024-02-05 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
fda
2seventy bio Announces New Strategic Path Forward
Published: 2024-01-30 (Crawled : 13:00) - biospace.com/
TSVT | $4.485 -3.34% 380K
|
|
| O: 11.17%
H: 12.63%
C: 3.35%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
REGN | $894.71 0.08% 180K
|
Health Technology
|
| O: 0.02%
H: 0.44%
C: 0.39%
Madrigal Pharmaceuticals Announces Additions to Its Leadership Team
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
MDGL | $207.53 -6.63% 360K
|
Health Technology
|
| O: 0.08%
H: 0.92%
C: 0.37%
pharmaceuticals
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.